Percutaneous methods of vector delivery in preclinical models

Area of Science:

• Cardiovascular Medicine
• Gene Therapy
• Molecular Biology

Background:

• Cardiovascular diseases are a major global health concern, driving significant hospitalization and mortality.
• While conventional treatments advance, novel therapies like cardiac gene therapy are emerging for clinical trials.
• Gene therapy's scope has expanded from monogenic to polygenic conditions, including heart failure, atherosclerosis, and arrhythmias.

Purpose of the Study:

• To review current in vivo vector-mediated cardiac gene delivery methods.
• To assess the merits and deficiencies of existing gene delivery techniques for cardiovascular applications.
• To inform the transition of cardiac gene therapy from preclinical research to clinical practice.

Main Methods:

• Review of existing literature on in vivo cardiac gene delivery systems.
• Analysis of vector-mediated delivery approaches.
• Evaluation of vector efficacy, safety, and targeting in cardiovascular contexts.

Main Results:

• Various vector-mediated delivery methods are available for cardiac gene therapy.
• Each method presents unique advantages and disadvantages regarding efficiency and targeting.
• Effective delivery to the heart remains a critical challenge for successful cardiovascular gene therapy.

Conclusions:

• Cardiac gene therapy holds significant potential for treating cardiovascular diseases.
• Understanding the nuances of in vivo vector delivery is crucial for therapeutic success.
• Further research and development in vector delivery systems are needed to overcome current limitations.